Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area Sort descending
  • Date Posted
Job Title Site Location Division Business Functional Area Sort descending Date Posted
Medical Affairs Lead (m/w/d), Solid Tumors Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Sep 06, 2024
Senior Scientist II Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Apr 24, 2024
Clinical Development Medical Director East Hanover USA Development Innovative Medicines Research & Development Apr 24, 2024
Medical Science Liaison Allergy / Derm MN, WI, ND, SD Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development Apr 25, 2024
Principal Scientist - Pathology Telangana India Biomedical Research Pharma Research Research & Development Sep 03, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Pharma Research Research & Development May 02, 2024
Senior Clinical Research Associate, Western Region Field Non-Sales (USA) USA Development Innovative Medicines Research & Development May 03, 2024
Clinical Data Specialist Hyderabad (Office) India Biomedical Research Pharma Research Research & Development May 07, 2024
Research Informatics Product Growth Manager x3 (US or Switzerland) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development May 08, 2024
Clinical Development Medical Director, Urology East Hanover USA Development Innovative Medicines Research & Development May 09, 2024
Regulatory Affairs Manager Kyiv Ukraine Development Innovative Medicines Research & Development May 10, 2024
Principal RWE Research Analyst Hyderabad (Office) India Operations CTS Research & Development May 14, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Country/ Cluster Head CRMA Ramallo (Argentina) Argentina Development Innovative Medicines Research & Development Aug 15, 2024
RA Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Sep 03, 2024
Clinical Research Medical Advisor Barcelona Gran Vía Spain Development Innovative Medicines Research & Development Sep 06, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Coordinator, Global Program Management and Portfolio Excellence INSURGENTES Mexico Biomedical Research CTS Research & Development Oct 15, 2024
Feasibility Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Oct 16, 2024
Medical Safety and Processes Manager Barcelona Gran Vía Spain Development Innovative Medicines Research & Development Oct 18, 2024
Medical Education Manager, Breast Cancer Montreal Canada International Innovative Medicines Research & Development Oct 18, 2024
Study Start Up Senior Lead Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Oct 18, 2024
RA Specialist Croatia Croatia Development Innovative Medicines Research & Development Oct 18, 2024
Senior Scientist I/II, Immunology– Immunogenicity and Mechanistic Immunology group Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 18, 2024
Senior Scientist - Target Biology and Discovery Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 18, 2024
Senior Patient Safety Specialist Seoul South Korea Development Innovative Medicines Research & Development Oct 20, 2024
Clinical Label Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 20, 2024
Director of Patient-Centered Outcomes London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 21, 2024
Expert - Medical Device Testing Laboratory (m/f/d) Schaftenau Austria Development Innovative Medicines Research & Development Oct 21, 2024
Study Start-Up Lead Shanghai (Shanghai) China Development Innovative Medicines Research & Development Oct 22, 2024
Senior Principal Scientist Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Oct 23, 2024
Tactical Planner Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 23, 2024
Principal Scientist II Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Oct 23, 2024
Medical Director, Renal London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 23, 2024
Medical Science Liaison - Breast Cancer Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 23, 2024
GMA Medical Director, RLT London (The Westworks) United Kingdom International Innovative Medicines Research & Development Oct 23, 2024
Senior Clinical Development Medical Director - Renal East Hanover USA Development Innovative Medicines Research & Development Aug 30, 2024
Renal Medical Lead Seoul South Korea International Innovative Medicines Research & Development Sep 01, 2024
Global Regulatory Publishing Associate London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 02, 2024
Regulatory Affairs CMC Senior Manager Schaftenau Austria Development Innovative Medicines Research & Development Sep 02, 2024
Global Regulatory Publishing Specialist London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 02, 2024
Manager Regulatory Affairs Process Excellence London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 02, 2024
Global Regulatory Submission Manager London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 02, 2024
Global Regulatory Affairs Manager Medical Devices (UK or Austria) London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 02, 2024
Manager Regulatory Policy & Intelligence London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 02, 2024
Regulatory Affairs Medical Device Manager (Schaftenau, Austria) Schaftenau Austria Development Innovative Medicines Research & Development Sep 02, 2024
Global Labeling Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 02, 2024
Director, Non-Clinical Statistics Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 02, 2024
Senior Expert, Science & Technology (Analytical Expert) Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
Medical Science Liaison West Bengal India International Innovative Medicines Research & Development Sep 02, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only